Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Live-cell imaging reveals multiple interactions between Epstein-Barr virus nuclear antigen 1 and cellular chromatin during interphase and mitosis.

Jourdan N, Jobart-Malfait A, Dos Reis G, Quignon F, Piolot T, Klein C, Tramier M, Coppey-Moisan M, Marechal V.

J Virol. 2012 May;86(9):5314-29. doi: 10.1128/JVI.06303-11. Epub 2012 Feb 15.

2.

DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndrome.

Lepagnol-Bestel AM, Zvara A, Maussion G, Quignon F, Ngimbous B, Ramoz N, Imbeaud S, Loe-Mie Y, Benihoud K, Agier N, Salin PA, Cardona A, Khung-Savatovsky S, Kallunki P, Delabar JM, Puskas LG, Delacroix H, Aggerbeck L, Delezoide AL, Delattre O, Gorwood P, Moalic JM, Simonneau M.

Hum Mol Genet. 2009 Apr 15;18(8):1405-14. doi: 10.1093/hmg/ddp047. Epub 2009 Feb 12.

PMID:
19218269
3.

RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1.

Caramel J, Quignon F, Delattre O.

Cancer Res. 2008 Aug 1;68(15):6154-61. doi: 10.1158/0008-5472.CAN-08-0115.

4.

The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors.

Caramel J, Medjkane S, Quignon F, Delattre O.

Oncogene. 2008 Mar 27;27(14):2035-44. Epub 2007 Oct 8.

PMID:
17922027
5.

Mangiferin protects against 1-methyl-4-phenylpyridinium toxicity mediated by oxidative stress in N2A cells.

Amazzal L, Lapôtre A, Quignon F, Bagrel D.

Neurosci Lett. 2007 May 17;418(2):159-64. Epub 2007 Mar 14.

PMID:
17433543
6.

Sustained mitotic block elicits DNA breaks: one-step alteration of ploidy and chromosome integrity in mammalian cells.

Quignon F, Rozier L, Lachages AM, Bieth A, Simili M, Debatisse M.

Oncogene. 2007 Jan 11;26(2):165-72. Epub 2006 Jul 10.

PMID:
16832348
7.

Complementation analyses suggest species-specific functions of the SNF5 homology domain.

Bonazzi V, Medjkane S, Quignon F, Delattre O.

Biochem Biophys Res Commun. 2005 Oct 21;336(2):634-8.

PMID:
16154112
8.

Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation.

El-Sabban ME, Nasr R, Dbaibo G, Hermine O, Abboushi N, Quignon F, Ameisen JC, Bex F, de Thé H, Bazarbachi A.

Blood. 2000 Oct 15;96(8):2849-55.

PMID:
11023521
9.

Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins.

Zhu J, Gianni M, Kopf E, Honoré N, Chelbi-Alix M, Koken M, Quignon F, Rochette-Egly C, de Thé H.

Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14807-12.

10.

Overexpressed BCL6 (LAZ3) oncoprotein triggers apoptosis, delays S phase progression and associates with replication foci.

Albagli O, Lantoine D, Quief S, Quignon F, Englert C, Kerckaert JP, Montarras D, Pinset C, Lindon C.

Oncogene. 1999 Sep 9;18(36):5063-75.

11.

Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells.

Bazarbachi A, El-Sabban ME, Nasr R, Quignon F, Awaraji C, Kersual J, Dianoux L, Zermati Y, Haidar JH, Hermine O, de Thé H.

Blood. 1999 Jan 1;93(1):278-83.

PMID:
9864171
12.

PML induces a novel caspase-independent death process.

Quignon F, De Bels F, Koken M, Feunteun J, Ameisen JC, de Thé H.

Nat Genet. 1998 Nov;20(3):259-65.

PMID:
9806544
13.

Potentiation of the virucidal activity of sterilized natural waters.

Quignon F, Gantzer C, Kiéné L, Schwartzbrod L.

Can J Microbiol. 1998 Feb;44(2):190-4.

PMID:
9543721
14.

Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein.

Chelbi-Alix MK, Quignon F, Pelicano L, Koken MH, de Thé H.

J Virol. 1998 Feb;72(2):1043-51.

15.

Retinoic acid and arsenic: towards oncogene-targeted treatments of acute promyelocytic leukaemia.

Quignon F, Chen Z, de Thé H.

Biochim Biophys Acta. 1997 Dec 9;1333(3):M53-61. Review. No abstract available.

PMID:
9426202
16.

Use of Doehlert matrices for study of poliovirus-1 adsorption.

Quignon F, Huyard A, Schwartzbrod L, Thomas F.

J Virol Methods. 1997 Oct;68(1):33-44.

PMID:
9395138
17.

Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies.

Koken MH, Reid A, Quignon F, Chelbi-Alix MK, Davies JM, Kabarowski JH, Zhu J, Dong S, Chen S, Chen Z, Tan CC, Licht J, Waxman S, de Thé H, Zelent A.

Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10255-60.

18.

Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia.

Zhu J, Koken MH, Quignon F, Chelbi-Alix MK, Degos L, Wang ZY, Chen Z, de Thé H.

Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3978-83.

19.

Poliovirus-1 inactivation and interaction with biofilm: a pilot-scale study.

Quignon F, Sardin M, Kiene L, Schwartzbrod L.

Appl Environ Microbiol. 1997 Mar;63(3):978-82.

20.

The PML and PML/RARalpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenic.

Andre C, Guillemin MC, Zhu J, Koken MH, Quignon F, Herve L, Chelbi-Alix MK, Dhumeaux D, Wang ZY, Degos L, Chen Z, de The H.

Exp Cell Res. 1996 Dec 15;229(2):253-60.

PMID:
8986606
21.

A functional N-myc2 retroposon in ground squirrels: implications for hepadnavirus-associated carcinogenesis.

Quignon F, Renard CA, Tiollais P, Buendia MA, Transy C.

Oncogene. 1996 May 2;12(9):2011-7.

PMID:
8649862
22.

[Effect of PML and PML-RAR on the transactivation properties and subcellular localization of steroid hormone receptors].

Guiochon-Mantel A, Savouret JF, Quignon F, Delabre K, Milgrom E, De The H.

Ann Endocrinol (Paris). 1996;57(2):91-100. French.

PMID:
8881287
23.

Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element.

Stadler M, Chelbi-Alix MK, Koken MH, Venturini L, Lee C, Saïb A, Quignon F, Pelicano L, Guillemin MC, Schindler C, et al.

Oncogene. 1995 Dec 21;11(12):2565-73.

PMID:
8545113
24.

Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors.

Guiochon-Mantel A, Savouret JF, Quignon F, Delabre K, Milgrom E, De The H.

Mol Endocrinol. 1995 Dec;9(12):1791-803.

PMID:
8614415
25.

Induction of the PML protein by interferons in normal and APL cells.

Chelbi-Alix MK, Pelicano L, Quignon F, Koken MH, Venturini L, Stadler M, Pavlovic J, Degos L, de Thé H.

Leukemia. 1995 Dec;9(12):2027-33.

PMID:
8609713
26.

Adenovirus infection induces rearrangements in the intranuclear distribution of the nuclear body-associated PML protein.

Puvion-Dutilleul F, Chelbi-Alix MK, Koken M, Quignon F, Puvion E, de Thé H.

Exp Cell Res. 1995 May;218(1):9-16.

PMID:
7737384
27.

The PML growth-suppressor has an altered expression in human oncogenesis.

Koken MH, Linares-Cruz G, Quignon F, Viron A, Chelbi-Alix MK, Sobczak-Thépot J, Juhlin L, Degos L, Calvo F, de Thé H.

Oncogene. 1995 Apr 6;10(7):1315-24.

PMID:
7731682

Supplemental Content

Loading ...
Support Center